Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Rodrigo Benedetti 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Rodrigo Benedetti)

Primary Source Intelligence • Q3 2024 Letter Analysis

Rodrigo Benedetti Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Rodrigo Benedetti. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Digest Analysis

Quick Take

"Active trading quarter capitalizing on August volatility with opportunistic longs in Applovin and Transmedics, subsequently sold on bounce. Low net exposure via index shorts."

Executive Summary

Rodrigo's Q3 letter details an active trading quarter driven by August's volatility spike from the Japanese yen carry trade unwind. He opportunistically increased exposure to names like Applovin and Transmedics during the selloff, subsequently selling on the bounce while rotating out of European defense stocks. The manager ended the quarter with low net exposure, having added index shorts late in the period to manage risk. Key themes include renewed interest in tankers due to Middle East tensions and potential dark fleet sanctions enforcement, continued value in select financials despite KRE's run-up, and a detailed analysis of Edwards Lifesciences as an asymmetric medical device opportunity following Q2 guidance cuts. The manager sees EW benefiting from TAVR market expansion and TMTT growth despite near-term competitive pressures. Portfolio positioning remains dynamic with readiness to increase exposure on market weakness. Short positions in ARKK, ASTS, and LUMN generated manageable losses despite strong performance in growth names during the quarter.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

62%

CautiousHigh

Moderate (62%)

Moderate conviction evidenced by specific position sizing decisions, detailed analysis of Edwards Lifesciences with clear thesis, and willingness to trade actively around volatility. Names specific holdings and provides detailed fundamental analysis, but maintains diversified approach with dynamic hedging.

Growth Outlook

25%

BearishBullish

Bearish (25%)

Manager acknowledges markets at all-time highs but sees selective opportunities in beaten down stocks. Mixed view with caution about election impacts and sector rotations, but identifies specific opportunities in tankers and medical devices.

Risk Appetite

38%

DefensiveAggressive

Defensive (38%)

Ended quarter with low net exposure and added index shorts late in quarter to manage risk. Dynamic positioning suggests defensive tilt while maintaining readiness to deploy on weakness.

Capital Deployment

43%

De-riskingDeploying

Net Neutral (43%)

Net reduction in risk exposure through addition of index shorts late in quarter and ending with low net exposure. While some opportunistic buying occurred during August selloff, these positions were subsequently sold, resulting in lower overall exposure.

Forward Guidance

0%

CautiousExpansionary

Cautious (0%)

Balanced approach with no clear directional bias. Manager will increase exposure if markets sell off but maintains current low exposure given market levels. Monitoring specific catalysts without rushing to deploy.

Language Signal

10%

BearishBullish

Bearish (10%)

Slightly more opportunity-focused language around tankers, financials, and medical devices, but balanced with risk awareness and defensive positioning. Uses terms like 'value' and 'asymmetric' while acknowledging headwinds.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Moderate risk awareness with specific concerns about election outcomes, geopolitical tensions, and market valuations at all-time highs. Manager acknowledges various headwinds but doesn't express systemic alarm, maintaining selective opportunity focus.

Opportunity Density

55%

ScarceAbundant

Selective (55%)

Selective opportunities identified in specific areas like tankers, certain financials, and medical devices despite broader market at highs. Manager finds value in beaten down stocks but characterizes environment as requiring selectivity rather than broad opportunity.

Time Horizon

45%

Short-TermLong-Term

Multi-Year (45%)

Mixed time horizon with active trading around volatility events but also longer-term fundamental analysis of companies like Edwards Lifesciences. Dynamic positioning suggests medium-term catalyst dependency rather than permanent holding mentality.